Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Jean E. Sanders(Carolinas Medical Center), E. Donnall Thomas(AbbVie (United States)), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William Levy, RP Witherspoon, D. B. Amos, CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Keith M. Sullivan(Duke Medical Center), F R Appelbaum(City Of Hope National Medical Center), K Doney(University of Washington Medical Center)
Cited by 325
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k